← Back to Search

Behavioural Intervention

Smartphone Apps for Smoking Cessation

N/A

Waitlist Available

Led By Jonathan B. Bricker

Research Sponsored by Fred Hutchinson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 and older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at the 3, 6, and 12-month follow-ups

Awards & highlights

No Placebo-Only Group

Summary

This trial compares two smartphone apps to help AIANs quit smoking; their smoking-related death rate is 6x higher than other groups.

Who is the study for?

This trial is for American Indians and Alaska Natives aged 18 or older who smoke daily, want to quit within the next month, can use a smartphone app in English, and are not using other quit-smoking aids. Participants must live off US tribal reservations or on certain Northern Plains reservations.

What is being tested?

The study compares two smartphone apps: iCanQuit, designed specifically to help AIANs stop smoking by teaching coping skills and motivation techniques; versus the existing NCI QuitGuide app. The effectiveness of these apps in aiding smoking cessation will be evaluated.

What are the potential side effects?

Since this trial involves behavioral interventions through smartphone applications rather than medications, there are no direct physical side effects associated with their use. However, participants may experience stress or frustration related to quitting smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at the 3, 6, and 12-month follow-ups

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at the 3, 6, and 12-month follow-ups

This trial's timeline: 3 weeks for screening, Varies for treatment, and at the 3, 6, and 12-month follow-ups for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

30-day point prevalence abstinence (PPA)

Secondary study objectives

30-day PPA

Self-reported 24-hour PPA

Self-reported 7-day PPA

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (iCanQuit app)Experimental Treatment3 Interventions

Participants use the iCanQuit app, which includes setting up a personalized quit plan, participating in eight levels of the content, receiving on-demand help in coping with smoking urges, and tracking their daily smoking behaviors for at least 45 days on study.

Group II: Arm II (NCI QuitGuide app)Active Control3 Interventions

Participants use the NCI QuitGuide app for at least 45 days on study.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Biospecimen Collection

2004

Completed Phase 3

~2030

Smoking Cessation Intervention

2005